Free Trial

Contineum Therapeutics (CTNM) SEC Filings & 10K Form

Contineum Therapeutics logo
$4.11 +0.12 (+3.01%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$4.08 -0.03 (-0.61%)
As of 04/15/2025 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Contineum Therapeutics SEC Filings

DateFilerForm TypeView
03/06/2025
3:08 PM
Contineum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2025
3:10 PM
Contineum Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2025
3:13 PM
Contineum Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2025
9:50 AM
Contineum Therapeutics (Subject)
SECTORAL ASSET MANAGEMENT INC (Filed by)
Form SCHEDULE 13G/A
01/31/2025
3:35 PM
Contineum Therapeutics (Issuer)
Stengone Carmine N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
3:38 PM
Contineum Therapeutics (Issuer)
Huhn Stephen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
3:38 PM
Contineum Therapeutics (Issuer)
Lorrain Daniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
3:40 PM
Contineum Therapeutics (Issuer)
Slover Peter T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:06 PM
Contineum Therapeutics (Issuer)
Lorrain Daniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
4:07 PM
Contineum Therapeutics (Issuer)
Lorrain Daniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
4:05 PM
Contineum Therapeutics (Subject)
Lorrain Daniel S. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
3:08 PM
Contineum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:10 PM
Contineum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
11:46 AM
Contineum Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G
08/14/2024
5:03 PM
Contineum Therapeutics (Issuer)
Huhn Stephen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
11:46 AM
Contineum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
11:19 AM
Contineum Therapeutics (Filer)
Form 8-K/A
06/24/2024
3:20 PM
Boyce Sarah (Reporting)
Contineum Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/24/2024
3:25 PM
Boyce Sarah (Reporting)
Contineum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
4:43 PM
Contineum Therapeutics (Issuer)
Healy John Stephen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/03/2024
4:46 PM
Contineum Therapeutics (Issuer)
Healy John Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:53 PM
Contineum Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:54 PM
Brady Todd R. (Reporting)
Contineum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:54 PM
Contineum Therapeutics (Issuer)
Lyons-Williams Lori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:55 PM
Contineum Therapeutics (Issuer)
Ware Olivia C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:56 PM
Contineum Therapeutics (Issuer)
Ignelzi Troy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:56 PM
Contineum Therapeutics (Issuer)
Huhn Stephen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:58 PM
Contineum Therapeutics (Issuer)
Lorrain Daniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:58 PM
Contineum Therapeutics (Issuer)
Slover Peter T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:59 PM
Contineum Therapeutics (Issuer)
Stengone Carmine N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
6:00 PM
Contineum Therapeutics (Issuer)
Ignelzi Troy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
6:03 PM
Contineum Therapeutics (Issuer)
Ignelzi Troy A. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/15/2024
3:38 PM
Contineum Therapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G
04/15/2024
3:20 PM
Contineum Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:CTNM) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners